Healthcare & Life Sciences
Jocasta Neuroscience
United States
series-a
series-a
Stage
1
Investors
About
Jocasta Neuroscience is a biotechnology company developing α‑klotho protein-based therapies aimed at treating cognitive decline related to various forms of dementia and neurodegeneration.
Explore Jocasta Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.